Related Experiment Video
Updated: Dec 1, 2025

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
Published on: August 18, 2015
COVID-19 Related Cerebrovascular Thromboembolic Complications in Three Young Patients
Khawaja Hassan Haroon1,2, Ahmad Muhammad1,2, Suhail Hussain1
1Neuroscience Institute, Hamad Medical Corporation, Doha, Qatar.
Insights
Patients with Coronavirus disease 2019 (COVID-19) face a higher risk of developing blood clots. This increased thrombosis risk is linked to excessive inflammation and platelet activation caused by the SARS-CoV-2 virus.
Area of Science:
- * Infectious Diseases and Virology
- * Hematology and Thrombosis
Background:
- * The global pandemic of Coronavirus disease 2019 (COVID-19), caused by the SARS-CoV-2 virus, presents significant challenges to healthcare systems worldwide.
- * COVID-19 is increasingly recognized for its association with coagulopathy, affecting both venous and arterial vascular systems.
Observation:
- * Patients diagnosed with COVID-19 exhibit a heightened susceptibility to thrombotic events.
- * The pathophysiology involves a complex interplay of excessive inflammation, platelet hyper-reactivity, and endothelial cell dysfunction.
Findings:
- * SARS-CoV-2 infection triggers a pro-thrombotic state, increasing the risk of blood clot formation.
- * Mechanisms contributing to COVID-19-related coagulopathy include systemic inflammation, platelet activation, endothelial injury, and venous stasis.
Implications:
- * Understanding the mechanisms of COVID-19-associated thrombosis is crucial for developing effective prevention and treatment strategies.
- * Clinical management of COVID-19 patients should consider the elevated risk of venous thromboembolism (VTE) and arterial thrombosis.
Abstract:
Coronavirus disease 2019 (COVID-19) is a viral illness, caused by the novel severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). It is currently affecting millions of people worldwide and is associated with coagulopathy, both in the venous and arterial systems. The proposed mechanism being excessive inflammation, platelet activation, endothelial dysfunction, and stasis. As an ongoing pandemic declared by WHO in March 2020, health systems worldwide are experiencing significant challenges with COVID-19-related complications. It has been noticed that patients with COVID-19 are at greater risk of thrombosis.
More Related Videos
13:10Combined Near-infrared Fluorescent Imaging and Micro-computed Tomography for Directly Visualizing Cerebral Thromboemboli
Published on: September 25, 2016
05:51Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain
Published on: July 24, 2016
Related Concept Videos
Venous Thrombosis I: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Pulmonary Embolism I: Introduction
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Aneurysm II: Clinical Manifestations and Diagnostic Studies